NSE: NH | BSE: 539551

Mid-range Performer

Download real time

1894.90 25.70 (1.37%)

257.2K NSE+BSE Volume

NSE 15 Sep, 2026 3:31 PM (IST)

38,724.3

Market Cap

High in industry

Beta 1Year

Very Low volatility

Narayana Hrudayalaya Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for NH, BSE:539551 Narayana Hrudayalaya Ltd.

Search Inside the pdf :

Narayana Hrudayalaya Ltd.

29 Jun 2026

1894.90

1.37%

Narayana Hrudayalaya

Buy: Narayana Hrudayalaya Ltd.

Target

ICICI Direct

Narayana Hrudayalaya Ltd.'s price crossed above 30Day SMA today

Narayana Hrudayalaya Ltd.

27 May 2026

1894.90

1.37%

Narayana Hrudayalaya (NARH IN) Q4FY26 Result Update India margins to sustain BUY

Buy: Narayana Hrudayalaya Ltd.

Target

Prabhudas Lilladhar

Narayana Hrudayalaya (NARH) reported strong EBITDA of INR5.1bn (up 43% YoY), 7% above PLe, led by another quarter of robust performance across India and Cayman operations along with the consolidation of UK subsidiary. The management reiterated its aggressive capex plan and commitment toward growing throughput over the next 3-4 years through debottlenecking, refurbishment and better bed mix. In the medium term, NARH intends to add ~1,535 beds over the next 3 years through greenfield and brownfield expansion across Bengaluru, Kolkata and Raipur. Our FY27E and FY28E EBITDA stands increased by 2-3%. We maintain BUY' rating with TP of INR2,250/share,...

Narayana Hrudayalaya Ltd. is trading below its 50 day SMA of 1929.3

Narayana Hrudayalaya Ltd.

27 May 2026

1894.90

1.37%

Narayana Hrudayalaya

Buy: Narayana Hrudayalaya Ltd.

Target

ICICI Direct

Q4FY26 - India, Cayman continue to do well - Revenues grew ~76% YoY to 2594 crore due to consolidation of recently acquired UK's PPG Hospital (like to like growth ~22%) . The India business grew ~13% growth to 1249.4 crore with an ARPOB of 50956 growing of ~10% YoY. There was a 48% growth in Cayman Hospitals to ~ 562 crore (Hospital business grew 15% YoY to ~436 crore and Insurance business grew 595% to ~126 crore). Consol. EBITDA grew 42% YoY to 510 crore mainly driven by ~32% growth in India EBITDA to ~ 311 crore (361 bps margin expansion to...

Narayana Hrudayalaya Ltd.'s price crossed above 30Day SMA today

Narayana Hrudayalaya Ltd.

24 Mar 2026

1894.90

1.37%

NARAYANA HRUDAYALAYA LIMITED

Hold: Narayana Hrudayalaya Ltd.

Recommendation Target

Geojit BNP Paribas

Narayana Health reported a healthy topline performance in 9MFY26, though EBITDA margins remained under pressure due to the ongoing integration of its U.K. operations. Looking ahead, the planned addition of ~1,500 beds over the next three to five years...

Narayana Hrudayalaya Ltd.'s price crossed above 30Day SMA today

Narayana Hrudayalaya Ltd.

06 Mar 2026

1894.90

1.37%

BP Equities Narayana Hrudaylaya Ltd. Shining Star Series BUY Target 2,110

Buy: Narayana Hrudayalaya Ltd.

BP Wealth

Narayana Hrudayalaya Ltd. is trading below its 50 day SMA of 1929.3

Narayana Hrudayalaya Ltd.

18 Feb 2026

1894.90

1.37%

Narayana Hrudayalaya (NARH IN) Q3FY26 Result Update Another strong quarter across India & Cayman BUY

Buy: Narayana Hrudayalaya Ltd.

Target

Prabhudas Lilladhar

Narayana Hrudayalaya (NARH) reported strong EBITDA of Rs4.4bn (up 44% YoY) adjusted for one time cost, 7% above our estimates driven by robust performance across India and Cayman operations along with consolidation of UK subsidiary. The Cayman business reported profitability of Rs1.88bn (up 42% YoY) adj for CHIL losses. India business reported healthy EBITDA adjusted for NHIC losses, up ~24% YoY. The management reiterated its aggressive capex...

Narayana Hrudayalaya Ltd.'s price crossed above 30Day SMA today

Narayana Hrudayalaya Ltd.

19 Dec 2025

1894.90

1.37%

Health for all. All for health.

Buy: Narayana Hrudayalaya Ltd.

Target

FundsIndia

Edge: High-acuity care + efficiency-led growth + ecosystem integration

Narayana Hrudayalaya Ltd. is trading below its 50 day SMA of 1929.3

Narayana Hrudayalaya Ltd.

04 Nov 2025

1894.90

1.37%

Narayana Hrudayalaya (NARH IN) Event Update Expands global...

Buy: Narayana Hrudayalaya Ltd.

Prabhudas Lilladhar

Narayana Hrudayalaya Ltd.'s price crossed above 30Day SMA today

Narayana Hrudayalaya Ltd.

20 Aug 2025

1894.90

1.37%

NARAYANA HRUDAYALAYA LIMITED

Sell: Narayana Hrudayalaya Ltd.

Target

Geojit BNP Paribas

In Q1FY26, Narayana Hrudayalaya delivered stable topline performance, though EBITDA margins were impacted by losses in the Integrated Care segment. The segment remains dilutive, with elevated costs weighing on consolidated profitability. With a pipeline of...

Narayana Hrudayalaya Ltd. is trading below its 50 day SMA of 1929.3

Is Narayana Hrudayalaya Ltd. worth buying?

231 Votes:

Buy 80.95%

Sell 14.29%

Hold 4.76%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf